Skip to main content

Table 1 Pathogenic variants and VUS identified from 2015 to 2018 in our laboratory by NGS.

From: Outcomes of 4 years of molecular genetic diagnosis on a panel of genes involved in premature aging syndromes, including laminopathies and related disorders

Patient

Age at referral

Indication

Gene

NM

Haplotype

cDNA change

Amino acid change

ACMG (default Intervar)

Details of Intervar

ACMG (Intervar reintepreted or manual-Maryland)

Additional criteria leading to the variant class change

ExAC

GnomAD

Mutation Taster

UMD-predictor

HSF

Literature

P1

11m

CL 2B

PYCR1

NM_006907.3

hoz

c.616G>A

p.(GLy206Arg)

LP

PM1 PM2 PP3 PP5

P

PS1 PP1

1/23214 (4.308e-05)

2/186106 (1.07e-5)

D0.99

P 100

Probably no impact on splicing

Kretz et al. 2011; Reversade et al. 2009

P2

26y

RTS

RECQL4

NM_004260.3

comp.het

c.2263C>T

p.(Arg755Trp)

VUS

PM1 PM2 PP3 BP1

LP

PM3

NA

1/240964 (4.15e-6)

NA

NA

Potential alteration of splicing

THIS REPORT

c.2415_2419dup

p.(Arg807fs113Ter)

NA

 

P

PM2 PVS1 PP3

NA

NA

NA

NA

Potential alteration of splicing

THIS REPORT

P3

9y2m

CL

ALDH18A1

NM_002860.4

het

c.413G>A

p.(Arg138Gln)

LP

PM1 PM2 PP2 PP3 PP5

P

PS1

NA

NA

D0.999

P 84

Potential alteration of splicing

Fischer-Zirnsak et al. 2015

P4

19y

BOFS

TFAP2A

NM_003220.3

het

c.710G>A

p.(Arg237Gln)

LP

PM1 PM2 PP2 PP3 PP5

P

PS1

NA

NA

D0.999

P 87

Potential alteration of splicing

Reiber et al. 2010 and p.(Arg237Gly) in Milunsky et al., 2010

P5

6m

CL

GORAB

NM_152281.2

comp.het

c.546A>T

p.(Glu182Asp)

VUS

PM2

LP

PM3 PP3 PP4

NA

NA

D0.999

PP72

Potential alteration of splicing

THIS REPORT

c.859C>T

p.(Arg287Ter)

VUS

PM2 PP3 PP5

P

PVS1 PM3

2/121244 (1.65e-05)

3/251106 (1.19e-5)

D1

P100

Probably no impact on splicing

THIS REPORT

P6

8m

RTS

RECQL4

NM_004260.3

comp.het

c.1573delT

p.Cys525AlafsTer33

NA

 

P

PVS1 PM2 PM3 PP5

27/104602 (2.581e-04)

69/276484 (2.5e-4)

NA

NA

Potential alteration of splicing

Kitao et al. 1999; Siitonen et al. 2009

c.2269C>T

p.(Gln757Ter)

P

PVS1 PM2 PP3 PP5

P

/

9/113308 (7.943e-05)

32/271122 (1.18e-4)

NA

NA

Potential alteration of splicing

Pujol et al.2000; Wang et al. 2003;Siitonen et al. 2009

P7

19y

Cockayne Sd

ERCC6

NM_000124.4

het

c.2291T>C

p.(Leu764Ser)

VUS

PM1 PM2 PP3 BP1

LP

PM3 (deletion of the other allele)

NA

NA

D0.999

P90

Probably no impact on splicing

THIS REPORT

P8

41y

Werner Sd

WRN

NM_000553.5

comp.het

c.2313T>A

p.(Cys771Ter)

P

PVS1 PM2 PP3

P

/

NA

1/251244 (3.98e-6)

D1

P100

Probably no impact on splicing

THIS REPORT

c.2665C>T

p.(Arg889Ter)

P

PVS1 PM2 PP3 PP5

P

/

4/120718 (3.314e-05)

6/251074 (2.39e-5)

D1

P100

Potential alteration of splicing

http://www.pathology.washington.edu/research/werner/database/

P9

43y

EDS

COL5A1

NM_000093.4

het

c.1884_1891del

p.(Asp629Phefs16Ter)

NA

 

LP

PVS1 PM2

NA

NA

NA

NA

Potential alteration of splicing

THIS REPORT

P10

24y

SHORT Sd

PIK3R1

NM_181523.2

het

c.1945C>T

p.(Arg649Trp)

LP

PM1 PM2 PP3 PP5

P

PS1 PP2

NA

NA

D0.999

P93

Potential alteration of splicing

Dyment et al. 2013

P11

63y

UPS

LMNA

NM_170707.4

het

c.1003C>T

p.(Arg335Trp)

VUS

PM2 PP3 PP5

P

PS1 PM1

NA

NA

D 0.999

P96

Probably no impact on splicing

Zaragova et al. 2017; Lambert et al., 2018

P12

37y

Buschke Ollendorf Sd

LEMD3

NM_014319.4

het

c.1323C>A

p.(Tyr441Ter)

VUS

PM2 PP3

P

PVS1 PS1 PP5

NA

NA

D1

P100

Potential alteration of splicing

Hellemans et al. 2006

P13

2m

CL

ALDH18A1

NM_002860.3

hoz

c.1499G>T

p.(Gly500Val)

LP

PM1 PM2 PP2 PP3

P

PP1 PM3

NA

0/239782 (0)

D0.99

P90

Potential alteration of splicing

THIS REPORT

P14

39y

EDS

COL5A1

NM_000093.4

comp.het

c.4030C>T

p.(Pro1344Ser)

VUS

PM2 PP3 BP1

VUS

/

NA

NA

D 0.999

P96

Potential alteration of splicing

THIS REPORT

c.2374C>T

p.(Arg792Ter)

P

PVS1 PM2 PP3 PP5

P

/

NA

NA

D1

P100

Potential alteration of splicing

Wenstrup et al. 2010

P15

36y

Brittle cornea

PRDM5

NM_018699.2

hoz

c.1036C>T

p.(Arg346Ter)

P

PVS1 PM2 PP3

P

/

3/119938 (2.501e-05)

3/244748 (1.23e-5)

D1

P100

Potential alteration of splicing

THIS REPORT

P16

6y7m

Oculoden-todigital dysplasia

GJA1

NM_000165.5

het

c.287T>A

p.(Val96Glu)

LP

PM1 PM2 PP2 PP3

P

PS1 PP5

NA

NA

D0.99

P100

NA

Wiest et al. 2006

P17

41y

EDS

LMNA

NM_005572.3 (Lamin C isoform)

het

c.1715G>A

p.(Arg572His)

VUS

PM2

VUS

/

NA

0/149540 (0)

Polym 0.992

Prob Polym

Probably no impact on splicing

THIS REPORT

P18

59y

Werner Sd

LMNA

NM_170707.4

het

c.1016C>T

p.(Ala339Val)

VUS

PM2 PP3

VUS

/

NA

NA

D0.999

P84

Potential alteration of splicing

THIS REPORT

P19

4m

UPS

RECQL4

NM_004260.3

hoz

c.2756-8G>T

p.?

NA

 

VUS

/

17/107602 (1.58e-04)

59/276606 (2.13e-4)

NA

NA

Probably no impact on splicing

THIS REPORT

P20

68y

EDS

ALDH18A1

NM_002860.4

het

c.1597G>A

p.(Val533Met)

VUS

PM1 PP2

VUS

/

NA

3/178100 (1.68e-5)

Polym 0,960

PP69

Probably no impact on splicing

THIS REPORT

P21

47y

EDS

COL1A2

NM_000089.3

het

c.798A>C

p.(Glu266Asp)

VUS

PM2

VUS

/

NA

2/282868 (7.07e-6)

D0,999

Polym45

Potential alteration of splicing

THIS REPORT

P22

20y

UPS

SYNE1

NM_182961.4

het

c.21209T>G

p.(Leu7070Trp)

VUS

BP1

VUS

/

NA

NA

Polym 0,890

P78

Potential alteration of splicing

THIS REPORT

P23a

21m

UPS

ATR

NM_001184.4

het

c.4750A>C

p.(Met1584Leu)

VUS

PM2

B

lack of segregation with the disease in the family

NA

3/251454 (1.19e-5)

D0,999

PP72

Potential alteration of splicing

THIS REPORT

P24a

17y

EDS

COL1A1

NM_000088.3

het

c.310G>A

p.(Asp104Asn)

VUS

PM2

B

lack of segregation with the disease in the family

NA

NA

Polym0,999

Polym33

Potential alteration of splicing

THIS REPORT

P25

57y

UPS

COL5A2

NM_000393.5

het

c.463C>T

p.(Arg155Cys)

VUS

PP3

VUS

/

1/49686 (2.013e-5)

7/209120 (3.35e-5)

D0,999

P100

Potential alteration of splicing

THIS REPORT

SYNE2

NM_182914.2

het

c.20632_20634delinsGAA

p.(Ser6878Glu)

NA

 

VUS

/

NA

NA

NA

NA

Potential alteration of splicing

THIS REPORT

P26a

65y

UPS

ATR

NM_001184.4

hoz

c.7701A>G

p.(Lys2567Lys)

VUS

BP4 BP7

B

lack of segregation with the disease in the family

NA

NA

D1

P77

Potential alteration of splicing

THIS REPORT

P27

21y

UPS

ELN

NM_001278913.1

het

c.1063_1086del

p.(355_362del)

NA

 

VUS

/

NA

NA

NA

NA

NA

THIS REPORT

P28

28y

EDS

TNXB

NM_019105.7

het

c.747C>T

p.(Cys249Cys)

LB

PM2 BP4 BP7

VUS

/

1/102780 (9.73e-06)

1/245798 (4.07e-6)

D1

Polym 11

Potential alteration of splicing

THIS REPORT

P29

57y

UPS

FBN1

NM_000138.4

het

c.5347A>T

p.(Ile1783Phe)

VUS

 

VUS

/

NA

NA

D0,999

P78

Potential alteration of splicing

THIS REPORT

P30

19y

EDS

ACAN

NM_013227.3

het

c.7205G>A

p.(Arg2402His)

VUS

PM1 PM2

VUS

/

8/119916 (6.671e-05)

20/248986 (8.03e-5)

D0,999

P87

Probably no impact on splicing

THIS REPORT

  1. Pathogenic variants are shown in bold, VUS are in plain text.athe variant has been searched in family, allowing us to reclassify a VUS into a benign variant, P23: the variant was absent from affected mother, P24 and P26: the variant was present in unaffected first degree relatives ; P7 also carried an heterozygous deletion of ERCC6 . yyears old,mmonths old,Sdsyndrome,RTSRothmund Thomson Syndrome,BOFSBranchiooculofacial syndrome,CLCutis laxa,EDSEhlers Danlos Syndrome,UPSUnspecified Progeroid syndrome,hetheterozygous,comp.hetcompound heterozygous,hozhomozygous,Ppathogenic,LPlikely pathogenic,VUSvariant of unknown significance,LBlikely benign,Bbenign,NAnot availabke,Ddisease causing,Polympolymorphism,Ppathogenic,PPprobably pathogenic. Intervar:http://wintervar.wglab.org/; Maryland:http://www.medschool.umaryland.edu/Genetic_Variant_Interpretation_Tool1.html/